Search

everythinglearnresearchcommunity

for

Search:↓

The research found that postmortem root bands in hair are likely caused by the breakdown of a specific part of the hair's inner structure after death.

The document says a skin condition called alopecia areata causes hair loss and stress, and is treated with strong skin creams, injections, or other therapies, but treatment success varies.

Ritlecitinib is effective and safe for treating alopecia areata, promoting significant hair regrowth.

Doctors in the Middle East need better treatments and more knowledge about new therapies for hair loss condition Alopecia Areata.

Lichen planopilaris in men often involves scalp redness and itching, with some also having hair loss, mucosal lichen planus, or thyroid disease, and treatment improved symptoms in nearly half of the cases.

A 4-year-old girl was diagnosed with trichotillomania, a condition where she pulls out her hair, which may resolve on its own or require therapy.

Unani medicine offers a natural, effective approach to treating hair loss with minimal side effects, but needs more scientific validation.

COVID-19 infection can significantly cause temporary hair loss.

Melatonin vitamin C-based nanovesicles improved hair growth and reduced hair loss in androgenic alopecia patients.

Injecting scalp tissue micrografts is a safe and effective treatment for hair loss after COVID-19.

Lichen planus on the scalp can cause scarring hair loss and has four main types.

The conclusion is that accurately replicating the complexity of the extracellular matrix in the lab is crucial for creating realistic human tissue models.

Some children may develop hair loss after having COVID-19.

COVID-19 may trigger sudden temporary hair loss.

Oxidative stress is likely important in causing telogen effluvium, and antioxidants might help treat it.

Adipose tissue-derived exosomes may help treat lichen planopilaris and preserve hair.

Female pattern hair loss is caused by multiple factors and while treatments like topical minoxidil, hormone therapy, and low-level light therapy can help, none can fully cure it.

Platelet-rich plasma, which carries growth factors, could be a promising treatment for non-scarring hair loss, promoting hair growth and density with no major side effects.

Telogen Effluvium is a condition causing excessive hair loss due to stress, illness, drugs, or hormonal changes, and can be treated with specific products or naturally resolves after 3-4 years.

The supplement improved hair growth and reduced hair loss in women.

New regenerative therapies show promise for treating hair loss.

Autologous platelet concentrates show promise in esthetic treatments but need more standardized research.

The document concludes that understanding hair follicle histology and the hair cycle is crucial for diagnosing alopecia.

Trichoscopy is a quick, accurate, and non-invasive method to diagnose and treat non-scarring hair loss.

ZIP10 is crucial for skin development and maintaining healthy skin.

Mutations in β1 integrins cause embryonic death but have milder effects on skin.

Wharton's jelly-derived stem cells were safely used to treat four alopecia patients, resulting in hair regrowth in all of them.

AIRE deficiency causes hair loss similar to alopecia areata in mice.

Cosmetic microneedles are promising for precise treatments but face challenges like skin damage and regulations.

Glass ceiling syndrome is linked to stress-related hair loss in female healthcare workers.